Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
- Ki Hyeong Lee
- , Byoung Chul Cho
- , Myung Ju Ahn
- , Yun Gyoo Lee
- , Youngjoo Lee
- , Jong Seok Lee
- , Joo Hang Kim
- , Young Joo Min
- , Gyeong Won Lee
- , Sung Sook Lee
- , Kyung Hee Lee
- , Yoon Ho Ko
- , Byoung Yong Shim
- , Sang We Kim
- , Sang Won Shin
- , Jin Hyuk Choi
- , Dong Wan Kim
- , Eun Kyung Cho
- , Keon Uk Park
- , Jin Soo Kim
- Chungbuk National University
- Yonsei University
- Samsung Medical Center, Sungkyunkwan university
- Kangbuk Samsung Hospital
- National Cancer Center Korea
- Seoul National University
- CHA University
- University of Ulsan
- Gyeongsang National University
- Inje University
- Yeungnam University
- Korea University
- Ajou University
- Gachon University
- Keimyung University
- Seoul National University Boramae Hospital
- Yuhan Corporation
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations